CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 105 enrolled
Drug / intervention
Mopatibehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04796610
NCT04796610N/ACompleted
CompareCT.gov

Mopati: A Pilot Hiv Treatment Partner Intervention In Botswana

RAND·interventional·Posted Mar 15, 2021·Updated Nov 1, 2023

In Brief

A clinical study evaluating Mopati for HIV. Completed, enrolled 105 participants across 1 site.

Detailed Summary

This study is a pilot test of the Mopati program ("partner" in Setswana), which is a multi-level intervention that guides healthcare providers and patients about treatment partner selection, and trains treatment partners on provision of effective support. The Specific Aims are: (1) To develop a multi-level treatment partner intervention with input from community and healthcare provider stakeholders in Botswana; and (2) To conduct a pilot test of the feasibility, acceptability, and preliminary effects on viral suppression.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV
CountriesBotswana
CollaboratorsBotswana Harvard AIDS Institute Partnership, Children's Mercy Hospital Kansas City, University of Botswana

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 15, 2021
Enrollment StartJun 17, 2021
Primary CompletionAug 31, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.3 years ago

Interventions

Mopatibehavioral

The intervention will provide training to health care providers on how to guide unsuppressed HIV patients in the selection of treatment partners. The Mopati program will provide education to patients and their treatment partners about HIV treatment and how treatment partners can support patients in treatment adherence.